BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23348222)

  • 1. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].
    Shiyovich A; Ben Zion IZ; Plakht Y; Amit G; Grosbard A; Katz A
    Harefuah; 2007 Aug; 146(8):594-8, 647. PubMed ID: 17853553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
    Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
    Kuhl EA; Sears SF; Vazquez LD; Conti JB
    J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
    James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
    Burns JL; Serber ER; Keim S; Sears SF
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and mental health predict early device-specific quality of life in patients receiving prophylactic implantable defibrillators.
    Carroll SL; Markle-Reid M; Ciliska D; Connolly SJ; Arthur HM
    Can J Cardiol; 2012; 28(4):502-7. PubMed ID: 22425267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in psychological distress and quality of life in patients with an ICD 1-year postimplant.
    Starrenburg A; Pedersen S; van den Broek K; Kraaier K; Scholten M; Van der Palen J
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):843-52. PubMed ID: 24697703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.
    Flemme I; Johansson I; Strömberg A
    J Clin Nurs; 2012 Feb; 21(3-4):311-21. PubMed ID: 21951323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
    Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
    Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
    Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reported outcomes and quality of life in Chinese patients with implantable cardioverter defibrillators
    Guo X; Tripp C; Huber NL; Hou C; Lv R; Li J; Liang T; Sears SF
    Heart Lung; 2021; 50(1):153-158. PubMed ID: 32553697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy.
    Ford J; Sears S; Ramza B; Reynolds DW; Nguyen P; Fedewa M; House J; Kennedy P; Thompson R; Murray C
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):43-51. PubMed ID: 24102945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.